Inactive Instrument

Press Releases Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

ThermoGenesis : Material Event - Form 8-K	Mar. 20	PU
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 13	PR
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update	Nov. 08	PR
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	23-10-26	PR
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	PR
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-10	PR
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update	23-08-08	PR
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	23-07-17	PR
ThermoGenesis : Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	23-07-17	PU
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update	23-05-15	PR
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update	23-05-10	PR
THERMOGENESIS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-30	AQ
THERMOGENESIS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)	23-03-30	AQ
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update	23-03-30	PR
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update	23-03-28	PR
THERMOGENESIS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-21	AQ
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	23-03-20	PR
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	23-03-16	PR
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies	23-03-15	PR
ThermoGenesis : Material Agreement - Form 8-K	23-03-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Press Releases

Filters